Serum miR-128-2 Serves as a Prognostic Marker for Patients with Hepatocellular Carcinoma

Circulating miRNAs are promising biomarkers for predicting the aggressiveness of hepatocellular carcinoma (HCC). We aimed to identify differentially expressed miRNAs in the serum of HCC patients with different Barcelona Clinic Liver Cancer (BCLC) stage, and to investigate the potential of serum miRN...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Liping, Xu, Litao, Wang, Peng, Meng, Zhiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313939/
https://www.ncbi.nlm.nih.gov/pubmed/25642945
http://dx.doi.org/10.1371/journal.pone.0117274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313939/
https://www.ncbi.nlm.nih.gov/pubmed/25642945
http://dx.doi.org/10.1371/journal.pone.0117274

Ejemplares similares